Abstract. ATP has broad functions as an autocrine / paracrine molecule. The mode of ATP release and its intracellular source, however, are little understood. Here we show that bradykinin via B 2 -receptor stimulation induces the extracellular release of ATP via the inositol 1,4,5-trisphosphate [Ins(1,4,5)P 3 ]-signaling pathway in cultured taenia coli smooth muscle cells. It was found that bradykinin also increased the production of Ins(1,4,5)P 3 and 2-APB-inhibitable [Ca
Introduction
ATP is thought to play a pivotal role as a functional mediator in the activation of ion channel type P2X receptors and G protein-coupled type P2Y receptors on a wide variety of cells (for review, see ref. 1) . Recent studies provide evidence that ATP as an autocrine / paracrine molecule is released extracellularly by mechanical and hypotonic stress from epithelial (2, 3) , hepatic (4, 5) , and red blood cells (6) and by receptor stimulation from glial (7) and smooth muscle cells (SMCs) (8, 9) . In cultured epithelial cells, the release of ATP induced by hypotonic stress has been shown to be suppressed by NPPB and DIDS, Cl − -channel blockers, and Gd 3+ , a blocker of stretch-activated channels (2, 10, 11) . Therefore it is likely that ATP moves out from the cells through a type of anionic channel after ionization to ATP 4− or [MgATP] 2− from ATP (12) . Furthermore, it has been considered that the cystic fibrosis transmembrane regulator protein (CFTR)-coupled Cl −1 channels (3, 13, 14) and the hemichannels of the cellular gap junction (15, 16) may contribute as the membrane machinery for ATP export. Our studies with rodent SMCs have revealed that various agonists, including ATP per se, are capable of releasing ATP from the vas deferens and ileal SMCs (8, 17, 18) . Furthermore, it has been demonstrated that adenosine, a metabolite of ATP, also releases ATP from the MDCK cells through a process regulated by a type of positive feedback system (19, 20) and that angiotensin AT 1 receptor-mediated ATP secretion is triggered by inositol 1,4,5-trisphosphate [Ins(1,4,5)P 3 ] signaling (9) . Aside from the SMCs, it has been shown that cardiac endothelial cells and glial cells release ATP in response to the stimulation of drug receptors with peptides and glutamate (7) . So far, however, the mechanism underlying the autocrine / paracrine type of release of ATP by receptor stimulation is still a matter of dispute. In addition, there is no report clearly identifying the intracellular source and synthetic pathway of the nucleotide involved in this process of the extracellular release. In recent studies, when bradykinin stimulates Gprotein-coupled B 2 receptors, intracellular Ca 2+ levels are controlled by dual systems, Ca
2+
-entry via the voltage-gated Ca 2+ channel and Ca 2+ release from the endoplasmic reticulum (ER) via the phospholipase CIns(1,4,5)P 3 signaling (21, 22) . From our findings with angiotensin II as described above, bradykinin was expected to elicit ATP release from the cells. The present study was designed to clarify the intracellular source of ATP and the Ca
-signaling involved in the bradykinin-induced release of ATP from cultured guinea-pig taenia coli SMCs. In addition, the implications of transient accumulation of ATP in the cells treated with 1% perchloric acid (PCA) are discussed.
Materials and Methods

Materials
NEM and oligomycin were purchased from Nakalai Tesque (Kyoto). Bradykinin, BAPTA / AM, 2-aminoethoxydiphenyl borate (2-APB), and thapsigargin were from Peptide Institute (Osaka), Dojindo (Kumamoto), Wako (Tokyo), and Alomone labs (Jerusalem, Israel), respectively. D-Myo-inositol 1,4,5-triphosphate P4(5)-(1-(2-nitrophenyl)ethylester trisodium salt [caged Ins(1,4,5)P 3 ] was from Invitrogen (Eugene, OR, USA). All other reagents were purchased from Sigma (St. Louis, MO, USA).
Cell culture
The study protocols were approved by Fukuoka University, Animal Care Committee. For a successful cell culture, neonatal, not adult, male guinea pigs within one day of birth were purchased from KBT-Oriental (Tosu) and used here. The guinea pigs were stunned and bled. Then, the taenia coli was removed and cut into segments in phosphate-buffered saline (PBS) supplemented with 0.25 mg / mL of collagenase. The segments were then moved to a CO 2 incubator (37°C) and maintained there for 40 min. Under a microscope, the longitudinal muscle layer was separated from the circular muscles and plexus with a pair of fine tweezers. After mincing, the small pieces were transferred to a PBS dish supplemented with 0.125% trypsin and placed in the incubator. Following trituration, the content was moved to a tube with 10% fetal bovine serum (FBS) and centrifuged at 180 × g for 5 min. The resulting pellet was dispersed in a culture medium, M-199 (Life Technologies, Rockville, MD), with 10% FBS and culturing in the incubator was started. On the third day, the cells were rinsed with fresh medium. After 4 days of culturing, the cells were used for the release experiment. The purity of SMCs cultured in this manner was checked by staining them with anti-α-actin under a fluorescence microscopy (data not shown).
Extracellular release of ATP
The cells collected from two dishes were trapped in a Millipore filter (pore size of 3 µm) and superfused at 0.5 mL / min using a peristaltic pump with oxygenated Krebs solution (37°C) of the following composition: 122 mM NaCl, 5.2 mM KCl, 2.4 mM CaCl 2 , 1.2 mM MgSO 4 , 25.6 mM NaHCO 3 , 11 mM D-glucose, 0.03 mM EDTA, and 0.1 mM ascorbic acid. After 20 min of equilibration, the superfusate was collected every 90 s for 15 min. The agonist was applied to the medium for the fifth to the seventh fractions and antagonists were present in the superfusion medium throughout the experiment. Superfusate (200 µL in each fraction) was transferred into microtubes and ATP measured with 100 µL of ATP reagent solution (Lucifel-LU; Kikkoman, Noda). The cell protein content was determined using a Bio-Rad protein assay kit II following cell lysis after overnight incubation (4°C) in deionized water containing 0.1% Triton X-100. Values for ATP released are expressed as pmol ⋅ mL −1 ⋅ mg protein −1 in the cultured cells.
Cytosolic accumulation of ATP
After 4 days of culture, the cells in the dishes were rinsed with 1 mL of HEPES-Tyrode solution (pH 7.4) of the following composition: 145 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgSO 4 , 10 mM HEPES, and 10 mM D-glucose. Then the cells were kept for 25 min in the solution (37°C) with and without test antagonists. After the cells had been exposed to the agonist, the dish medium was replaced with 1% PCA solution (pH 1.11) or the cell lysis buffer containing 1% Triton-X at each time point (10, 20, 30 , and 60 s). The experiment with the PCA solution was undertaken as follows. The dishes were immediately placed on ice for 30 min, after which the cells were collected mechanically and placed in polyester tubes. After centrifugation (10,000 × g) for 10 min, the supernatant was placed in new tubes and diluted 10,000 × with HEPES-Tyrode solution to neutralize the medium. The amounts of ATP in 200 µL of supernatant were measured as described above. The precipitate was solubilized with 0.1% Triton X-100. Then the insoluble layer that remained after centrifugation was homogenized with a microhomogenizer. In the experiment with the cell lysis buffer, the amounts of ATP in 200 µL sampling medium from each dish were measured as described above. The protein content of the cells was determined as described above. Values for ATP accumulated are expressed as nmol ⋅ mL −1 ⋅ mg protein −1 , or percent accumulation from the basal.
Measurement of Ins(1,4,5)P 3
The SMCs in cultured wells were rinsed using 37°C HEPES solution of the following composition: 145 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgSO 4 , 10 mM HEPES, and 10 mM D-glucose (pH 7.4). After exposure of the test peptide to the well, 4% PCA was added at appropriate time points (every 10 to 30 s and then at 60 and 120 s) to stop the synthesis of phosphoinositides. Thereafter, the cells were maintained for 30 min in a refrigerator and isolated mechanically. The suspended cells were transferred to a polyester tube and centrifuged at 10,000 × g for 8 min at 4°C. The supernatant was then placed in a new tube and adjusted to pH 7.0 using 1.5 M KOH. After further centrifugation, the supernatant was collected in a sample tube for the measurement of Ins(1,4,5)P 3 . The amounts of Ins(1,4,5)P 3 in the supernatant (100 µL) were determined in duplicate using a radio receptor assay with a D-myo-inositol (1,4,5)trisphosphate [H 3 ] assay kit, TRK 1000 (Amersham Biosciences, Piscataway, NJ, USA), as reported previously (9) . Values of the accumulated Ins(1,4,5)P 3 are expressed as pmol / mg protein.
Photoliberation of caged Ins(1,4,5)P 3
The cells (4 days culturing) in the dish were loaded with 1 µM caged Ins(1,4,5)P 3 in 1 mL HEPES-Tyrode (pH 7.4, 37°C) containing 50 µM EDTA for 1 h as reported by Parker and Ivorra (23) and then kept for 1 h in the caged compound-free solution. To exclude ATP leaked into the dish medium, the cells were washed three times by the normal solution before starting the experiment. The photoliberation of caged Ins(1,4,5)P 3 was carried out by placing the dish on a stage located 50 mm under a xenon flash lamp. Then, amounts of ATP released into the dish medium by a single photoflash (250 µs) through a filter (340 nm) with a short arc power strobe (SA-100; Nisshin Electric Co., Tokyo) were measured from 200 µL sample medium by using luciferin / luciferase as described above. The UV energy applied to a dish was 150 mJ / 10 mm 2 per one flash through the filter. Simultaneously, the cells were quickly immersed with 1% PCA and kept for 1 h on ice. The intracellular accumulation of ATP was measured as described previously.
Measurement of [Ca
2+
] i The cells cultured in a glass-bottomed dish were loaded with fluo4 / AM (10 µM; Molecular Probes, Eugene, OR, USA) in the dark for 20 min at 25°C, rinsed, and then kept in the HEPES solution until the start of the experiment. The composition of the solution was as follows: 136.9 mM NaCl, 5.9 mM KCl, 1.0 mM CaCl 2 , 4.2 mM HEPES, and 5.6 mM D-glucose (pH 7.4). The microscopic study was carried out under superfusion (1.2 mL/ min) of the cells with the solution. The fluorescence intensities were determined at wavelengths of Ex, 470 nm, and Em, 520 nm. Images were obtained using a cooled CCD camera (Dage MTI, Michigan City, IN, USA) with an image intensifier unit (C-9016-01; Hamamatsu Photonics, Hamamatsu) attached to the Nikon Diaphot inverted microscope (Nikon, Tokyo). Experimental data were analyzed using Metamorph Software (Universal Imaging, West Chester, PA, USA). The fluorescence image on one frame was obtained by a 20x accumulation. The experiment was continued until approximately 120 frames had been obtained. F 0 is the fluorescence intensity of the first frame. F was normalized by F 0 .
Confocal laser microscopy
The cells cultured in a glass-bottomed dish were loaded with a marker of ERs, 1 µM ER-Tracker Red (a marker of ERs), and Mito-Tracker Green (a marker of mitochondria) (both from Molecular Probes) at room temperature for 20 min, rinsed, and then kept in the HEPES solution for an appropriate time. Microscopic observation was carried out with superfusion of the cells, as described above. The living cells were observed and photographed using a confocal scanner (CSU10; Yokogawa, Tokyo) attached to the fluorescent microscopic system described above and further equipped with a krypton / argon laser as the light source. The ERTracker Red images were captured by excitation at 568 nm and emission at 590 nm. The Mito-Tracker Green images were obtained by excitation at 488 nm and emission at 520 nm.
Statistics
Differences between multiple means were tested for statistical significance by one-way analysis of variance (ANOVA) followed by Dunnett's test. A value of P<0.05 was considered to be significant.
Results
Involvement of Ins(1,4,5)P 3 signals in the release of ATP with bradykinin
In the superfusing experiment, bradykinin (0.01 -1 µM) caused the extracellular release of ATP from cultured taenia coli SMCs in a concentration-dependent manner (Fig. 1A) . The evoked release of ATP was strongly repressed by HOE140, a B 2 -receptor antagonist, but not by [des-Arg 10 ]-HOE140, a B 1 -receptor antagonist (Fig. 1B) . Upon the evoked release of ATP, the effects of inhibitors involved in the Ins(1,4,5)P 3 -signaling pathway were evaluated. The extracellular release of ATP was almost completely blocked by U-73122, a phospholipase C inhibitor; thapsigargin, a Ca 2+ -ATPase inhibitor; and BAPTA / AM, an intracellular Ca 2+ chelator. Furthermore, the release of ATP was markedly reduced by N-ethylmaleimide (NEM), a G-protein inhibitor (24, 25) (Fig. 2A) . In the measurement of Ins(1,4,5)P 3 accumulation, bradykinin enhanced the production of Ins(1,4,5)P 3 in the cultured cells. This effect reached a peak 10 -20 s after the administration of bradykinin; however, it was prevented by treatment with HOE140 and U-73122 (Fig. 2: B and C) .
In
2+
-release from the ER. The second response / first response was 82.5 ± 2.6% and 3.2 ± 0.8% with and without 2-APB, respectively (Fig. 2D ). These findings indicate that the release of ATP is mediated by the Ins(1,4,5)P 3 signaling pathway from the membrane of the B 2 receptor to the ER.
Effects of Ca
2+ entry blockers, mitochondrial inhibitors and brefeldin A on the evoked release of ATP
The effects of Ca 2+ -entry blockers on the release of ATP were evaluated. Nifedipine and verapamil, voltagegated Ca
2+
-channel blockers, markedly inhibited the release of ATP. SN-6, an inhibitor of the Na + -Ca 2+ exchanger (NCX) (26, 27) , almost completely suppressed the release (Fig. 3A) . Furthermore, the effects of inhibitors of the functions of organelles, such as mitochondria, were tested. In this regard, rotenone and oligomycin, inhibitors of mitochondrial ATP synthesis, showed a negative influence, although not a significant one, on the release of ATP. Similarly, brefeldin A, a transport inhibitor of the Golgi complex, failed to suppress the release of ATP (Fig. 3B) .
ATP release triggered by photoliberation of caged Ins(1,4,5)P 3
The cells were loaded with 1 µM caged Ins(1,4,5)P 3 for 1 h and then Ins(1,4,5)P 3 liberated by flash photolysis increased the release of ATP. Amounts of ATP released into the dish medium were measured 10 s after a single photoflashing. The value was approx. 2.5 times higher than that of the basal release of ATP via only a photoflashing from the cells unloaded with the caged compound. The enhanced release of ATP was suppressed in the presence of 50 µM 2-APB, an Ins(1,4,5)P 3 -receptor antagonist (28, 29) (Fig. 4) . However, we failed to detect a positive change in the amounts of cytosolic ATP in the cells treated with 1% PCA solution because of a momentary phenomenon (data not shown).
Cytosolic accumulation of ATP induced by bradykinin
Cell membranes were destroyed with 1% PCA solution in the corresponding time course after exposure to 1 µM of bradykinin. Thereafter, the amounts of ATP were measured from the cultured dishes. Such accumulation culminated 10 s after exposure to the peptide and then gradually declined to the basal level within 60 s. The peak accumulation of ATP amounted to 132 nmol ⋅ mL −1 ⋅ mg protein −1 (Fig. 5A ). At 10 s, the evoked cytosolic accumulation decreased significantly in the presence of thapsigargin, 2-APB, and NEM. However, the evoked accumulation of ATP was uninfluenced by nifedipine, verapamil, and SN-6 (Fig. 5B ). These observations suggest that the cytosolic accumulation of ATP is affected by inhibitors such as thapsigargin, which may constitute the intracellular component of ATP release. On the other hand, the non-effective drugs, such as nifedipine, are thought to have no effect on the intracellular release of ATP, although they respond to its extracellular release. The accumulation of ATP after exposure to the cell lysis buffer (1% Triton-X) for 1 min amounted to 635.3 ± 52.0 nmol ⋅ mL −1 ⋅ mg protein −1 (n = 7). This was unaltered in the presence of 1 µM bradykinin (645.1 ± 37.0 nmol ⋅ mL −1 ⋅ mg protein −1 , n = 9). On the other hand, the accumulation of ATP after the PCA solution for 1 min was 101.8 ± 10.0 nmol ⋅ mL −1 ⋅ mg protein −1 (n = 7). In the study involving the confocal laser scanning microscope, fluorescence signal intensities in the cells stained with ER-Tracker Red and Mito-Tracker Green were almost unaltered by treatment with 1% PCA ]i indicate the first response /second response to bradykinin in the absence and presence of 2-APB, respectively (n = 6 -9). The interval between the first response and second response is 20 min; 2-APB was added to the superfusate 10 min before the second application of bradykinin. Typical data are shown in the left panel (a). **P<0.01, compared with the control.
solution, indicating that the ER and mitochondria remain morphologically unchanged even after destruction of the cell membrane (Fig. 6) . However, thereafter, these images quickly disappeared within 70 s after treatment with the cell lysis buffer containing 1% Triton-X.
Discussion
The mode of bradykinin-induced release of ATP from the cultured SMCs of guinea-pig taenia coli was assessed in this study. The extracellular release of ATP was dependent on concentration and sensitive to the B 2 receptor. B 2 receptor-mediated release was suppressed by a phospholipase C inhibitor U-73122 and inhibitors of the Ins(1,4,5)P 3 signal to the ER, thapsigargin and BAPTA/ AM. Herein, thapsigargin and BAPTA / AM were utilized for blocking Ca
2+
-storage in the ER and Ca
-supply to the ER, respectively. The level of ] i was lowered to the basal level by 2-APB, an Ins(1,4,5)P 3 -receptor antagonist on the ER. Therefore, these findings indicate that the signal induced by stimulation of the B 2 receptor arrives in the ER via the phospholipase C-Ins(1,4,5)P 3 signaling pathway, as has been reported to occur with angiotensin II (9) .
It has been shown that besides the predominant Ca
release from the intracellular store, stimulation of the B 2 -receptor with 1 µM bradykinin produces action potential discharge and thus, leads to an enhanced influx of external Ca 2+ . The bradykinin-induced response was inhibited by nifedipine and verapamil (30) . In the present study, the release of ATP evoked by the peptide was attenuated by nifedipine and verapamil, voltagegated Ca
-channel blockers, and further by SN-6, an inhibitor of NCX. The reverse mode NCX (rNCX) is considered to operate when the cell membrane depolarizes in the presence of bradykinin. Therefore, activation of rNCX enhances Ca
-influx and the enhanced Ca 2+ mobilization may be abrogated by the NCX inhibitors KB-R7943 and SN-6 (31, 32) .
In the study with a caged compound, the amounts of ATP in the cultured dish were increased by photoliberation of Ins(1,4,5)P 3 and the enhanced release of ATP was reduced by 2-APB. Unfortunately, we could not detect an accumulation of ATP in the cells treated with PCA because of an instantaneous change in the amounts of ATP. Judging from the negative effects of inhibitors of mitochondria and Golgi complex such as oligomycin and brefeldin A on the extracellular release, it appears unlikely that these organellae are the direct cytosolic sources of ATP. A line of our findings suggest that there is an intimate correlation between accumulation or release of ATP and Ins(1,4,5)P 3 -mediated Ca 2+ signals from the ER. It is noteworthy that every event relating to ER, the evoked-peak production of Ins(1,4,5)P 3 , the release of ATP by photoliberation of caged Ins(1,4,5)P 3 , and the evoked-peak accumulation of ATP in the PCAtreated cells occurred 10 -20 s after the stimulation. These findings may further support the idea that ER is a key organelle in the bradykinin-inducible ATP release from the cultured SMCs.
Our major concern is to know a transient change of cytosolic ATP amounts after administration of bradykinin. To evaluate the cytosolic accumulation of ATP evoked by bradykinin, the cells were treated with a PCA solution. The fixation of cells with PCA solution, unlike Triton-X in the cell lysis buffer, has been widely employed to measure the intracellular production of Ins(1,4,5)P 3 as shown in Fig. 2 . Therefore, on the basis of this principle, the transient cytosolic accumulation of ATP could be measured as fixed amounts of the nucleotide in some state. However, if an organelle like mitochondria is destroyed by the PCA-treatment, it might be difficult to measure the precise amounts of ATP because of a leakage of large amounts of ATP from mitochondria. In the confocal laser scanning microscopic studies, fluorescence signal intensities in the cells stained with ER-Tracker Red and Mito-Tracker Green, organelle markers (33) were virtually unaffected in the PCA solution. However, thereafter, these images were quickly abolished by switching to the cell lysis buffer. From these observations, the morphological configuration of the ER and mitochondria seems to still be preserved even after the fixation of the cells treated with the PCA solution. Additionally, the amounts of the cytosolic accumulation of ATP measured by treatment with the cell lysis buffer were approx. six-times higher than that by treatment with the PCA solution, indicating that the value of the former includes the leakage of ATP from these organellae. We found that the cytosolic transient accumulation of ATP from the cells treated with PCA culminated 10 s after exposure to bradykinin. The evoked-peak accumulation of ATP was prevented by thapsigargin, NEM, and 2-APB but not by nifedipine, verapamil, and SN-6. This shows that at least these Ca 2+ -entry blockers respond only to the extracellular release of ATP induced by bradykinin. The evoked-extracellular release of ATP is thought to mainly come from the cytosol. However, it is supposed that the transient accumulation of ATP in the cells treated with PCA may come from the ER because the accumulation was only suppressed by 2-APB and thapsigargin that inhibit ER functions, but not by inhibitors (nifedipine and verapamil) of the extracellular release of ATP.
Accumulated studies show the possibility that the source of cytosolic free ATP is, in part, the ER. Pfeffer and Rothman (34) presented a working hypothesis that an ATP transporter exists in the ER membrane because ATP is synthesized primarily in the mitochondria and must become available in the lumen of the ER for energy requirements and phosphorylation. The present study demonstrated that although not significantly, the mitochondrial inhibitors, rotenone and oligomycin, tended to attenuate the extracellular release of ATP. This might be indicative of ATP mobilization from the mitochondria to the ER. The yeast phosphoinositide phosphatase Sac1p localizes to the ER membranes. Retention of Sac1p in the ER stimulates ATP transport into the ER lumen (35, 36) . Moreover, it has been shown that the pyridine nucleotide pool, although it is not the adenine nucleotide pool, exists in the lumen of the rat hepatic ER, indicating the existence of a redox system in the lumen (37) .
In conclusion, bradykinin via B 2 receptor stimulation elicits the extracellular release of ATP, which is mediated by the Ins(1,4,5)P 3 -induced Ca 2+ signaling and finally leads to a Ca 
